About the company
Freenome is a biotech company developing blood-based cancer screening tests using multiomics signals and machine learning. The company’s lead focus has been colorectal cancer screening, alongside broader early detection ambitions. Freenome hires across wet lab, assay development, clinical operations, and supporting software and data functions. Public company updates also show Freenome has gone through restructuring in recent years.